Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
Eyebright Medical Gains SIX Swiss Exchange Approval for GDR Offering
January 19, 2025
Company
Deals
Teddy Clinical Research Lab Partners with Cerba Research for Global Services
January 19, 2025
Company
Deals
Junshi Biosciences’ COVID-19 Therapy Faces Supply Issues, Partners with Sihuan Pharma
January 20, 2025
Company
Deals
Macrolux Secures Series A Funding for Endoscopy Solutions
January 20, 2025
Company
Deals
Hua Medicine Receives Milestone Payment from Bayer for Dorzagliatin
January 20, 2025
Company
Drug
SciClone Pharmaceuticals Files for Hong Kong Market Approval of Danyelza
January 20, 2025
Company
Deals
Asia Regenerative Medicine Raises Pre-Series A+ Funding for Bioartificial Organs
January 20, 2025
Company
Deals
Beijing Smart Beam Raises Series A+ Funding for CT X-Ray Tube Development
January 20, 2025
Company
Deals
Asieris Partners with ReviR Therapeutics for Urogenital Cancer Research
January 20, 2025
Company
Siemens Healthineers Reports Q1 Revenue Drop Amid COVID-19 Impact
January 20, 2025
Company
Astellas Pharma Reports Strong Q3 Results with 17.3% Revenue Growth
January 20, 2025
Company
Drug
Fujian Cosunter’s HBV Therapy GST-HG141 Begins Phase II Trial
January 20, 2025
1
2
…
1,035
1,036
1,037
1,038
1,039
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
